Roche secures CE mark for ovarian cancer detection test
Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, for the identification of epithelial ovarian cancer (EOC) patients suitable for targeted therapy with AbbVie’s ELAHERE ( …